{ "ok": true, "cik": "1735438", "ticker": "MGTX", "name": "MeiraGTx Holdings plc", "filings": [ { "form": "8-K", "filed": "2026-09-23", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/0001104659-26-109824-index.htm" }, { "form": "10-Q", "filed": "2026-08-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926095504/0001104659-26-095504-index.htm" }, { "form": "8-K", "filed": "2026-08-13", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926095491/0001104659-26-095491-index.htm" }, { "form": "8-K", "filed": "2026-07-07", "items": [ "1.01 Entry into a Material Definitive Agreement", "1.02 Termination of a Material Definitive Agreement", "2.03 Creation of a Direct Financial Obligation", "3.02 Unregistered Sales of Equity Securities", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926080949/0001104659-26-080949-index.htm" }, { "form": "8-K", "filed": "2026-06-15", "items": [ "5.07 Submission of Matters to a Vote of Security Holders" ], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926074085/0001104659-26-074085-index.htm" }, { "form": "10-Q", "filed": "2026-05-14", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1735438/000110465926060739/0001104659-26-060739-index.htm" } ], "events12m": 13, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001735438.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735438" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up MeiraGTx Holdings plc ($MGTX). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-23. 13 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 81391000, "revenueGrowth1y": 1.4457165179242164, "revenueGrowthPerYear": 0.21214864027826486, "yearsOfData": 5, "operatingMargin": -1.3019621334054134, "operatingMarginPrior": -4.934403077015535, "netMargin": -1.4031158236168617, "operatingCashFlow": -46359000, "capitalSpending": 3826000, "freeCashFlow": -50185000, "researchAndDevelopment": 129619000, "researchShareOfRevenue": 1.5925470875158187, "cash": 65931000, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 37701000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 15920000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 14017000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 33279000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 81391000 } ], "totalEquity": -5793000, "totalAssets": 244430000, "equityRatio": -0.023700036820357567, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -1.42, "sharesOutstanding": 80430186, "bookValuePerShare": -0.07202519710696678, "revenuePerShare": 1.011945937809966, "range80": { "low": 47193269.950098395, "high": 537488159.7349051, "baseline": 169636029.00311038, "n": 749, "band": "b00", "bandLabel": "$50M–100M", "method": "v4.1", "credibility": 0.625, "growthYears": 6, "ownVolatility": 0.7165693734604469, "classVolatility": 0.19293522228976231, "volatility": 0.5786871277844668 }, "ifPaceHeld": { "low": 47193269.950098395, "high": 537488159.7349051 } }, "edgarette": "🔖 Exposure: revenue $81.4M (FY2025). Experience: revenue up 144.6% on the year, up 21.2% a year over 4 years; operating margin -130.2%, up from -493.4%. Soundness: equity -2.4% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $47.2M and $537.5M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $51.7M to $493.5M. A range, not a forecast. Against peers (31 filers, $50M+ revenue, biological products, (no diagnostic substances)): operating margin -130.2% against a -15.8% median; growth 144.6% against 21.4%.", "peers": { "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2836", "growth": [ 0.2145, 27 ], "opMargin": [ -0.1582, 31 ], "equityRatio": [ 0.5857, 31 ], "returnOnEquity": [ -0.0646, 25 ] }, "summary": "MeiraGTx Holdings (MGTX) grew revenue 145% in FY2025 to $81 million, operating margin -130% against a -15.8% median for biological products, (no diagnostic substances), equity -2.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
MeiraGTx Holdings plc against its own record and its peers
Operating marginPeer median -15.8%-130.2%Revenue, on the yearPeer median 21.4%144.6%Equity of assetsPeer median 58.6%-2.4%Gold tick: the median of 31–31 peers with $50M+ revenue in biological products, (no diagnostic substances)
", "chartHorizon": null, "backtest": { "tests": 3, "hits": 3, "rate": 1, "method": "v4", "byYear": { "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-24T14:21:58.471Z", "hash": "f2c92d620cefb62c", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "MeiraGTx Holdings (MGTX) grew revenue 145% in FY2025 to $81 million, operating margin -130% against a -15.8% median for biological products, (no diagnostic substances), equity -2.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 81391000, "totalDebt": null, "cash": 65931000 }, "experience": { "revenueGrowth1y": 1.4457165179242164, "revenueGrowthPerYear": 0.21214864027826486, "operatingMargin": -1.3019621334054134, "operatingMarginPrior": -4.934403077015535, "netMargin": -1.4031158236168617, "freeCashFlow": -50185000 }, "soundness": { "equityRatio": -0.023700036820357567, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "2836", "growth": [ 0.2145, 27 ], "opMargin": [ -0.1582, 31 ], "equityRatio": [ 0.5857, 31 ], "returnOnEquity": [ -0.0646, 25 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 47193269.950098395, "high": 537488159.7349051, "baseline": 169636029.00311038, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 749, "sizeBand": "$50M–100M", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341 }, "credibility": { "weightOnOwnRecord": 0.625, "growthYears": 6, "ownVolatility": 0.7165693734604469, "classVolatility": 0.19293522228976231, "pricedVolatility": 0.5786871277844668, "k": 3 }, "stress": { "low": 51719159.51625864, "high": 493519979.1246389, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 3, "hits": 3, "rate": 1, "method": "v4", "byYear": { "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-09-24T14:21:58.471Z", "hash": "f2c92d620cefb62c", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001735438.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735438" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }